MLEC Quote, Financials, Valuation and Earnings

American Shared Hospital Services has a net margin of -166.47% compared to Moolec Science SA's net margin of -2.96%. Moolec Science SA's return on equity of -93.42% beat American Shared Hospital Services's return on equity of 13.75%.

Moolec Science SA has a consensus price target of --, signalling upside risk potential of 347.69%. On the other hand American Shared Hospital Services has an analysts' consensus of $4.84 which suggests that it could grow by 78.6%. Given that Moolec Science SA has higher upside potential than American Shared Hospital Services, analysts believe Moolec Science SA is more attractive than American Shared Hospital Services.

Moolec Science SA has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison American Shared Hospital Services has a beta of 0.424, suggesting its less volatile than the S&P 500 by 57.593%.

Moolec Science SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. American Shared Hospital Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Moolec Science SA pays -- of its earnings as a dividend. American Shared Hospital Services pays out -- of its earnings as a dividend.

Moolec Science SA quarterly revenues are $1.5M, which are smaller than American Shared Hospital Services quarterly revenues of $7M. Moolec Science SA's net income of -$2.5M is lower than American Shared Hospital Services's net income of -$207K. Notably, Moolec Science SA's price-to-earnings ratio is -- while American Shared Hospital Services's PE ratio is 7.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Moolec Science SA is 4.69x versus 0.64x for American Shared Hospital Services. Usually stocks with elevated PS ratios are considered overvalued.

Auna SA has a net margin of -166.47% compared to Moolec Science SA's net margin of 2.26%. Moolec Science SA's return on equity of -93.42% beat Auna SA's return on equity of 6.56%.

Moolec Science SA has a consensus price target of --, signalling upside risk potential of 347.69%. On the other hand Auna SA has an analysts' consensus of $13.35 which suggests that it could grow by 97.78%. Given that Moolec Science SA has higher upside potential than Auna SA, analysts believe Moolec Science SA is more attractive than Auna SA.

Moolec Science SA has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Auna SA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Moolec Science SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Auna SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Moolec Science SA pays -- of its earnings as a dividend. Auna SA pays out 0.81% of its earnings as a dividend. Auna SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Moolec Science SA quarterly revenues are $1.5M, which are smaller than Auna SA quarterly revenues of $285.9M. Moolec Science SA's net income of -$2.5M is lower than Auna SA's net income of $6.5M. Notably, Moolec Science SA's price-to-earnings ratio is -- while Auna SA's PE ratio is 18.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Moolec Science SA is 4.69x versus 0.43x for Auna SA. Usually stocks with elevated PS ratios are considered overvalued.

Eurofins Scientific SE has a net margin of -166.47% compared to Moolec Science SA's net margin of --. Moolec Science SA's return on equity of -93.42% beat Eurofins Scientific SE's return on equity of 7.71%.

Moolec Science SA has a consensus price target of --, signalling upside risk potential of 347.69%. On the other hand Eurofins Scientific SE has an analysts' consensus of -- which suggests that it could fall by --. Given that Moolec Science SA has higher upside potential than Eurofins Scientific SE, analysts believe Moolec Science SA is more attractive than Eurofins Scientific SE.

Moolec Science SA has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Eurofins Scientific SE has a beta of 0.731, suggesting its less volatile than the S&P 500 by 26.881%.

Moolec Science SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Eurofins Scientific SE offers a yield of 1.01% to investors and pays a quarterly dividend of $0.54 per share. Moolec Science SA pays -- of its earnings as a dividend. Eurofins Scientific SE pays out 23.52% of its earnings as a dividend. Eurofins Scientific SE's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Moolec Science SA quarterly revenues are $1.5M, which are larger than Eurofins Scientific SE quarterly revenues of --. Moolec Science SA's net income of -$2.5M is higher than Eurofins Scientific SE's net income of --. Notably, Moolec Science SA's price-to-earnings ratio is -- while Eurofins Scientific SE's PE ratio is 23.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Moolec Science SA is 4.69x versus 1.39x for Eurofins Scientific SE. Usually stocks with elevated PS ratios are considered overvalued.